Beyer Marc, Schultze Joachim L
Molecular Tumor Biology and Tumor Immunology, Clinic I for Internal Medicine, University of Cologne, Kerpenerstr. 62/Haus 16 UG, 50931 Cologne, Germany.
Curr Oncol Rep. 2008 Mar;10(2):130-6. doi: 10.1007/s11912-008-0021-z.
Regulatory T cells (T(reg) cells) are a highly specialized subset of immune cells capable of specifically suppressing autoreactive cells and thereby preventing autoimmunity. T(reg) cells also play an important role in limiting the immune reaction in infectious diseases. In the context of malignancies, however, accumulation of T(reg) cells occurs in the tumor microenvironment. T(reg) cells have been associated with prevention of antitumor immunity and the evasion of efficient recognition of tumor antigens. In the past few years, several approaches have been developed to target and deplete T(reg) cells in the context of tumors. Overall, these interventions have the potential to eliminate T(reg) cells and thereby help strengthen antitumor immunity by vaccination.
调节性T细胞(T(reg)细胞)是一种高度特化的免疫细胞亚群,能够特异性抑制自身反应性细胞,从而预防自身免疫。T(reg)细胞在限制传染病中的免疫反应方面也发挥着重要作用。然而,在恶性肿瘤的情况下,T(reg)细胞会在肿瘤微环境中积累。T(reg)细胞与抗肿瘤免疫的预防以及肿瘤抗原有效识别的逃避有关。在过去几年中,已经开发出几种方法来在肿瘤环境中靶向和清除T(reg)细胞。总体而言,这些干预措施有可能消除T(reg)细胞,从而通过疫苗接种帮助增强抗肿瘤免疫力。